We tested the functional significance of RANK signaling by treating L363-xenotransplanted mice, finding that early RANKL blockade significantly slowed myeloma progression and extended disease-free survival in this aggressive model (Fig. 6e). The gene discussed is TNFRSF11A; the disease is plasma cell myeloma.